Versant Capital Management »

Jade Biosciences shares owned by Versant Capital Management

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.1k 393 15.43

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vaneck Gold Miners Etf Etf (GDX)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
Versant Venture Management
Rtw Investments
Frazier Life Sciences Management
Driehaus Capital Management
Avidity Partners Management
RA Capital Management
Standard Life Aberdeen
Soleus Capital Management
Geode Capital Management

View all funds holding Jade Biosciences